Drug
Rocbrutinib
Rocbrutinib: highest development phase Phase 3, developed by Newave Pharmaceutical Inc. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Newave Pharmaceutical Inc
Trials
| Drug | Phase | Indication |
|---|---|---|
| Rocbrutinib NCT07342478 | Phase 3 | CLL / SLL |
Latest
No recent events.
Follow Rocbrutinib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.